Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yosuke Wasaki"'
Autor:
Xiaohui Guo, Yang Yu, Yongbo Zhang, Li Sun, Yufeng Li, Bing Song, Li Hang, Masayuki Baba, Yosuke Wasaki, Kunika Kikumori, Emiko Murayama
Publikováno v:
Pain and Therapy, Vol 13, Iss 4, Pp 937-952 (2024)
Abstract Introduction There is no approved effective drug for diabetic peripheral neuropathic pain (DPNP) in China. Gabapentinoids including mirogabalin have shown promise, although data in Chinese patients are scarce. Methods This phase 3, multicent
Externí odkaz:
https://doaj.org/article/c3f2001e2c064e97977406da79a42222
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 693-698 (2020)
Abstract Aims/Introduction Diabetic peripheral neuropathic pain (DPNP) affects the functionality, mood and sleep patterns of patients with diabetes. Mirogabalin, an α2δ ligand with a slower dissociation for α2δ‐1 versus α2δ‐2 subunits, show
Externí odkaz:
https://doaj.org/article/477b8407b59244d497c1f4f700568085
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 5, Pp 1299-1306 (2019)
Abstract Aims/Introduction This study evaluated the efficacy and safety of mirogabalin, a novel, potent, selective ligand of the α2δ subunit of voltage‐dependent Ca2+ channels, for the treatment of diabetic peripheral neuropathic pain (DPNP). Mat
Externí odkaz:
https://doaj.org/article/caf6f6b119684d1097ef75687af44b2e
Autor:
Tokiko Fukuda, Tetsuya Ito, Takashi Hamazaki, Ayano Inui, Mika Ishige, Reiko Kagawa, Norio Sakai, Yoriko Watanabe, Hironori Kobayashi, Yosuke Wasaki, Junki Taura, Yuki Imamura, Tsutomu Tsukiuda, Kimitoshi Nakamura
Publikováno v:
Journal of Inherited Metabolic Disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e1af065968315ba2f5fc1ffecc52f1f
https://doi.org/10.1002/jimd.12610
https://doi.org/10.1002/jimd.12610
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 693-698 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Diabetic peripheral neuropathic pain (DPNP) affects the functionality, mood and sleep patterns of patients with diabetes. Mirogabalin, an α2δ ligand with a slower dissociation for α2δ‐1 versus α2δ‐2 subunits, showed effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9448339a638c23c631fc8da8e3febd8
https://doaj.org/article/477b8407b59244d497c1f4f700568085
https://doaj.org/article/477b8407b59244d497c1f4f700568085
Autor:
Yoshihiro Kakehi, Masanori Kuroha, Yosuke Wasaki, Masayuki Baba, Emiko Murayama, Jitsu Kato, Shoichi Ohwada
Publikováno v:
Clinical Therapeutics. 43:822-835.e16
Mirogabalin besylate has been approved in several countries to treat peripheral neuropathic pain. This pooled analysis, using data from the two pivotal Phase III studies in Asian patients with diabetic peripheral neuropathic pain and post-herpetic ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6459ca93ca46ed723574c05483e3a02
https://doi.org/10.1016/j.clinthera.2021.03.015
https://doi.org/10.1016/j.clinthera.2021.03.015